Cargando…

A combined approach for individualized lymphadenectomy in gastric cancer patients

Introduction: Gastric cancer ranks as the fifth most common cancer globally. The presence of lymph node metastasis is a significant prognostic factor influencing survival. Postoperative morbidity and nodal staging accuracy are heavily affected by the extent of lymph node dissection. Our study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Varga, Zsolt, Bíró, Adrienn, Török, Miklós, Tóth, Dezső
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338685/
https://www.ncbi.nlm.nih.gov/pubmed/37456519
http://dx.doi.org/10.3389/pore.2023.1611270
_version_ 1785071679023611904
author Varga, Zsolt
Bíró, Adrienn
Török, Miklós
Tóth, Dezső
author_facet Varga, Zsolt
Bíró, Adrienn
Török, Miklós
Tóth, Dezső
author_sort Varga, Zsolt
collection PubMed
description Introduction: Gastric cancer ranks as the fifth most common cancer globally. The presence of lymph node metastasis is a significant prognostic factor influencing survival. Postoperative morbidity and nodal staging accuracy are heavily affected by the extent of lymph node dissection. Our study aimed to explore the potential integration of two contemporary methods, sentinel node navigation surgery (SNNS) and the Maruyama Computer Program (MCP), to improve the accuracy of nodal staging. Materials and methods: We conducted a prospective data collection involving patients with gastric adenocarcinoma from 2008 to 2018 at the Department of Surgery, University of Debrecen, Hungary. Data from 100 consecutive patients were collected. The primary and secondary endpoints included evaluating the rate of node-negative patients and the diagnostic accuracy of our combined approach. Results: Sentinel node mapping was successful in 97 out of 100 patients. We found that using the threshold value of the Maruyama Index (MI) ≥ 28, all metastatic stations of sentinel-node-negative patients could be identified. Our method achieved 100% sensitivity and negative predictive value, with a specificity of 60.42% (95% CI = 46.31%–72.98%). Discussion: The combined application of SNNS and MCP has proven to be an effective diagnostic technique in the synergistic approach for identifying metastasis-positive lymph node stations. Despite its limitations, this combination may assist clinicians in customizing lymphadenectomy for gastric cancer patients.
format Online
Article
Text
id pubmed-10338685
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103386852023-07-14 A combined approach for individualized lymphadenectomy in gastric cancer patients Varga, Zsolt Bíró, Adrienn Török, Miklós Tóth, Dezső Pathol Oncol Res Pathology and Oncology Archive Introduction: Gastric cancer ranks as the fifth most common cancer globally. The presence of lymph node metastasis is a significant prognostic factor influencing survival. Postoperative morbidity and nodal staging accuracy are heavily affected by the extent of lymph node dissection. Our study aimed to explore the potential integration of two contemporary methods, sentinel node navigation surgery (SNNS) and the Maruyama Computer Program (MCP), to improve the accuracy of nodal staging. Materials and methods: We conducted a prospective data collection involving patients with gastric adenocarcinoma from 2008 to 2018 at the Department of Surgery, University of Debrecen, Hungary. Data from 100 consecutive patients were collected. The primary and secondary endpoints included evaluating the rate of node-negative patients and the diagnostic accuracy of our combined approach. Results: Sentinel node mapping was successful in 97 out of 100 patients. We found that using the threshold value of the Maruyama Index (MI) ≥ 28, all metastatic stations of sentinel-node-negative patients could be identified. Our method achieved 100% sensitivity and negative predictive value, with a specificity of 60.42% (95% CI = 46.31%–72.98%). Discussion: The combined application of SNNS and MCP has proven to be an effective diagnostic technique in the synergistic approach for identifying metastasis-positive lymph node stations. Despite its limitations, this combination may assist clinicians in customizing lymphadenectomy for gastric cancer patients. Frontiers Media S.A. 2023-06-29 /pmc/articles/PMC10338685/ /pubmed/37456519 http://dx.doi.org/10.3389/pore.2023.1611270 Text en Copyright © 2023 Varga, Bíró, Török and Tóth. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pathology and Oncology Archive
Varga, Zsolt
Bíró, Adrienn
Török, Miklós
Tóth, Dezső
A combined approach for individualized lymphadenectomy in gastric cancer patients
title A combined approach for individualized lymphadenectomy in gastric cancer patients
title_full A combined approach for individualized lymphadenectomy in gastric cancer patients
title_fullStr A combined approach for individualized lymphadenectomy in gastric cancer patients
title_full_unstemmed A combined approach for individualized lymphadenectomy in gastric cancer patients
title_short A combined approach for individualized lymphadenectomy in gastric cancer patients
title_sort combined approach for individualized lymphadenectomy in gastric cancer patients
topic Pathology and Oncology Archive
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338685/
https://www.ncbi.nlm.nih.gov/pubmed/37456519
http://dx.doi.org/10.3389/pore.2023.1611270
work_keys_str_mv AT vargazsolt acombinedapproachforindividualizedlymphadenectomyingastriccancerpatients
AT biroadrienn acombinedapproachforindividualizedlymphadenectomyingastriccancerpatients
AT torokmiklos acombinedapproachforindividualizedlymphadenectomyingastriccancerpatients
AT tothdezso acombinedapproachforindividualizedlymphadenectomyingastriccancerpatients
AT vargazsolt combinedapproachforindividualizedlymphadenectomyingastriccancerpatients
AT biroadrienn combinedapproachforindividualizedlymphadenectomyingastriccancerpatients
AT torokmiklos combinedapproachforindividualizedlymphadenectomyingastriccancerpatients
AT tothdezso combinedapproachforindividualizedlymphadenectomyingastriccancerpatients